Abbvie to record $3.5 bln charge related to schizophrenia drug - Reuters

Reuters | Jan. 10, 2025, 11:06 a.m. | Original
Abbvie to record $3.5 bln charge related to schizophrenia drug Reuters
Wall St Week Ahead Inflation report could rattle markets after bond yields climb - Reuters JPMorgan asks staff to return to office five days a week from March, memo shows - Reuters